<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Antimicrobial prophylaxis for gynecologic and obstetric surgery in adults*</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Antimicrobial prophylaxis for gynecologic and obstetric surgery in adults*</h1>
<div class="graphic"><div class="figure"><div class="ttl">Antimicrobial prophylaxis for gynecologic and obstetric surgery in adults*</div><div class="cntnt"><table cellspacing="0"><colgroup span="5" width="20%"></colgroup> <tbody> <tr> <td class="subtitle1">Procedure</td> <td class="subtitle1">ACOG preferred regimen<sup>¶</sup><sup>[1,2]</sup></td> <td class="subtitle1">Dose</td> <td class="subtitle1">Alternative regimens<sup>Δ</sup><sup>[3,4]</sup></td> <td class="subtitle1">Dose</td> </tr> <tr> <td class="divider_bottom" rowspan="14"> <p>Hysterectomy (abdominal, including supracervical, vaginal, laparoscopic, or robotic)</p> Pelvic reconstruction procedures, including colporrhaphy or those involving mesh or vaginal sling placement</td> <td class="divider_bottom" rowspan="14">Cefazolin, cefoxitin or cefotetan</td> <td class="divider_bottom" rowspan="14"> <p>Cefazolin:</p> <p class="indent1">&lt;120 kg: 2 g IV</p> <p class="indent1">≥120 kg: 3 g IV</p> <br/> <p>Cefoxitin or cefotetan:</p> <p class="indent1">2 g IV</p> </td> <td class="subtitle2_left" colspan="2">Regimen:</td> </tr> <tr class="divider_bottom"> <td class="indent1">Ampicillin-sulbactam</td> <td>3 g IV</td> </tr> <tr> <td class="subtitle2_left" colspan="2">Regimen:</td> </tr> <tr> <td class="indent1">Clindamycin <strong>OR</strong></td> <td>900 mg IV<sup>◊</sup></td> </tr> <tr> <td class="indent1">Vancomycin<sup>¶</sup></td> <td>15 mg/kg IV (not to exceed 2 g per dose)</td> </tr> <tr> <td class="indent2" colspan="2"><strong>PLUS</strong> one of the following:</td> </tr> <tr> <td class="indent1">Gentamicin <strong>OR</strong></td> <td>5 mg/kg IV (if overweight or obese, based on adjusted body weight)<sup>§</sup></td> </tr> <tr> <td class="indent1">Aztreonam <strong>OR</strong></td> <td>2 g IV</td> </tr> <tr class="divider_bottom"> <td class="indent1">Fluoroquinolone<sup>¶</sup><sup>¥</sup></td> <td> </td> </tr> <tr> <td class="subtitle2_left" colspan="2">Regimen:</td> </tr> <tr> <td class="indent1">Metronidazole</td> <td>500 mg IV</td> </tr> <tr> <td class="indent2" colspan="2"><strong>PLUS</strong> one of the following:</td> </tr> <tr> <td class="indent1">Gentamicin <strong>OR</strong></td> <td>5 mg/kg IV (if overweight or obese, based on adjusted body weight)<sup>§</sup></td> </tr> <tr class="divider_bottom"> <td class="indent1">Fluoroquinolone<sup>¶</sup><sup>¥</sup></td> <td> </td> </tr> <tr> <td class="divider_bottom" rowspan="3">Cesarean delivery (intact membranes, not in labor)</td> <td class="divider_bottom" rowspan="3">Cefazolin</td> <td class="divider_bottom" rowspan="3"> <p>&lt;120 kg: 2 g IV</p> ≥120 kg: 3 g IV</td> <td>Clindamycin</td> <td>900 mg IV<sup>◊</sup></td> </tr> <tr> <td class="indent2" colspan="2"><strong>PLUS</strong></td> </tr> <tr class="divider_bottom"> <td>Gentamicin</td> <td>5 mg/kg IV (if overweight or obese, based on adjusted body weight)<sup>§</sup></td> </tr> <tr> <td class="divider_bottom" rowspan="5">Cesarean delivery (in labor, ruptured membrane)</td> <td>Cefazolin</td> <td> <p>&lt;120 kg: 2 g IV</p> &gt;120 kg: 3 g IV</td> <td>Clindamycin</td> <td>900 mg IV</td> </tr> <tr> <td class="indent1" colspan="2"><strong>PLUS</strong></td> <td class="indent1" colspan="2"><strong>PLUS</strong></td> </tr> <tr> <td class="divider_bottom" rowspan="3">Azithromycin</td> <td class="divider_bottom" rowspan="3">500 mg IV</td> <td>Gentamicin</td> <td>5 mg/kg IV (if overweight, or obese, based on adjusted body weight)</td> </tr> <tr> <td class="indent1" colspan="2"><strong>PLUS</strong></td> </tr> <tr class="divider_bottom"> <td>Azithromycin</td> <td>500 mg IV</td> </tr> <tr class="divider_bottom"> <td>Uterine evacuation (including surgical abortion, suction D&amp;C, and D&amp;E)</td> <td>Doxycycline</td> <td>200 mg orally</td> <td> </td> <td> </td> </tr> <tr class="divider_bottom"> <td>Hysterosalpingogram, including chromotubation or saline infusion sonography</td> <td colspan="4">Not recommended<sup>‡</sup></td> </tr> <tr class="divider_bottom"> <td>Laparotomy without entry into bowel or vagina</td> <td>Consider cefazolin</td> <td> <p>&lt;120 kg: 2 g IV</p> ≥120 kg: 3 g IV</td> <td> </td> <td> </td> </tr> <tr> <td> <p>Laparoscopy (diagnostic, tubal sterilization, operative except for hysterectomy)</p> Other transcervical procedures: <ul class="decimal_heading"> <li>Cystoscopy<sup>†</sup> </li> <li>Hysteroscopy (diagnostic or operative) </li> <li>Intrauterine device insertion </li> <li>Endometrial biopsy </li> <li>Oocyte retrieval </li> <li>D&amp;C for non-pregnancy indication </li> <li>Cervical tissue biopsy, including LEEP or endocervical curettage </li> </ul> </td> <td colspan="4">Not recommended</td> </tr> </tbody></table></div><div class="graphic_footnotes">ACOG: American College of Obstetricians and Gynecologists; 

	IV: intravenous; 

	D&amp;C: dilation and curettage; 

	D&amp;E: dilation and evacuation; 

	LEEP: loop electrosurgical excision procedure; 

	IDSA: Infectious Diseases Society of America; 

	ASHP: American Society of Health-System Pharmacists; 

	HSG: hysterosalpingogram; 

	PID: pelvic inflammatory disease.<br/>	

	* Common pathogens: Enteric gram-negative bacilli, anaerobes, group B <em>Streptococcus</em>, enterococci.<br/>	

	¶ Parenteral prophylactic antimicrobials can be given as a single IV dose begun within 60 minutes before the procedure. If vancomycin or a fluoroquinolone is used, the infusion should be given over 60 to 90 minutes and started within 60 to 120 minutes before the initial incision.<br/>	

	Δ An alternative regimen should be used in women with history of immediate hypersensitivity to beta-lactam agents. Due to increasing resistance of <em>Escherichia coli</em> to ampicillin-sulbactam and fluoroquinolones, local sensitivity profiles should be reviewed prior to use.<br/>
<span class="lozenge">◊</span> When clindamycin prophylaxis is warranted, UpToDate authors prefer a single dose of 900 mg based upon pharmacokinetic considerations according to 2013 IDSA/ASHP surgical antibiotic prophylaxis guidelines.<sup>[3]</sup> However, a 600 mg dose consistent with ACOG guidance may be sufficient.<sup>[1,2]</sup><br/>	

	§ Gentamicin use for surgical antibiotic prophylaxis should be limited to a single dose given preoperatively. Based on evidence from colorectal procedures, a single dose of approximately 5 mg/kg gentamicin appears more effective for the prevention of surgical site infection than multiple doses of gentamicin 1.5 mg/kg every 8 hours.<sup>[4]</sup> For overweight and obese patients (ie, actual weight is &gt;125% of ideal body weight), a dosing weight should be used. A calculator to determine ideal body weight and dosing weight is available in UpToDate.<br/>	

	¥ Ciprofloxacin 400 mg IV <strong>OR</strong> levofloxacin 500 mg IV <strong>OR</strong> moxifloxacin 400 mg IV. Fluoroquinolones are contraindicated in pregnancy and in women who are breastfeeding.<br/>	

	‡ Antimicrobial prophylaxis is recommended for women undergoing HSG or chromotubation with a history of PID or abnormal tubes noted on HSG or laparoscopy. For these women, an antibiotic prophylaxis regimen of doxycycline, 100 mg twice daily for 5 days, can be considered to reduce the incidence of post-procedural PID.<sup>[5,6]</sup> For women undergoing chromotubation, a single preoperative 2 gram dose of intravenous cefazolin is recommended, and the patient can be discharged on the same doxycycline regimen recommended for abnormal HSG.<br/>	

	† Most clinicians exclude urinary tract infection with a urinalysis before cystoscopy, with subsequent urine culture performed to confirm findings suggestive of infection. Patients with positive test results should be given antibiotic treatment.</div><div class="graphic_reference">References:

	<ol>
<li>ACOG practice bulletin No. 195: Prevention of infection after gynecologic procedures. Obstet Gynecol 2018; 131:e172.</li>
<li>ACOG practice bulletin No. 199: Use of prophylactic antibiotics in labor and delivery. Obstet Gynecol 2018; 132:e103.</li>
<li>Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm 2013; 70:195.</li>
<li>Zelenitsky SA, Silverman RE, Duckworth H, Harding GK. A prospective, randomized, double-blind study of single high dose versus multiple standard dose gentamicin both in combination with metronidazole for colorectal surgical prophylaxis. J Hosp Infect 2000; 46:135.</li>
<li>Pittaway DE, Winfield AC, Maxson W, et al. Antibiotic prophylaxis for gynecologic procedures prior to and during the utilization of assisted reproductive technologies: a systematic review. Am J Obstet Gynecol 1983; 147:623.</li>
<li>Pereira N, Hutchinson AP, Lekovich JP, et al. Antibiotic prophylaxis for gynecologic procedures prior to and during the utilization of assisted reproductive technologies: a systematic review. J Pathog 2016; 2016:4698314.</li>
</ol>

	Adapted from: Antimicrobial prophylaxis for surgery. Med Lett Drugs Ther 2016; 58:63.</div><div id="graphicVersion">Graphic 87200 Version 36.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
